UPDATE 1-Celgene profit down but tops expectations; keeps forecast

April 24 (Reuters) - Celgene Corp on Thursday reported a slightly higher-than-expected first-quarter profit on increased sales of its flagship multiple myeloma drug Revlimid and other oncology products.